ARA-C AND AMSA IN THE THERAPY OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA

被引：0
|
作者：
JAGER, U [1 ]
机构：
[1] VIENNA UNIV,MED KLIN 1,A-1010 VIENNA,AUSTRIA
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 1986年 / 98卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：589 / 589
页数：1
相关论文
共 50 条
  • [1] ARA-C AND AMSA FOR TREATMENT OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA
    JAGER, U
    LECHNER, K
    SCHWARZINGER, I
    BETTELHEIM, P
    BOGNAR, H
    GEISSLER, K
    HAAS, O
    HINTERBERGER, W
    KOS, M
    LEITHA, T
    NEUMANN, E
    PANZER, S
    POLLAK, C
    BLUT, 1986, 53 (03): : 145 - 145
  • [2] SMALL DOSES OF ARA-C IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA - DIFFERENTIATION OF MYELOID-LEUKEMIA CELLS
    HOUSSET, M
    DANIEL, MT
    DEGOS, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (01) : 125 - 129
  • [3] SUCCESSFUL SALVAGE TREATMENT WITH CLOFARABINE AND CYTARABINE (ARA-C) IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
    Malato, A.
    Santoro, A.
    Felice, R.
    Magrin, S.
    Turri, D.
    Di Bella, R.
    Salemi, D.
    Acquaviva, F.
    Scime, R.
    Fabbiano, F.
    HAEMATOLOGICA, 2013, 98 : 31 - 31
  • [4] TREATMENT OF REFRACTORY AND RECIDIVIST ACUTE MYELOID-LEUKEMIA WITH HIGH-DOSE ARA-C AND AMSACRINE
    KALHS, P
    KOS, M
    JAGER, U
    SCHWARZINGER, I
    BETTELHEIM, P
    PANZER, S
    HINTERBERGER, W
    NEUMANN, E
    LECHNER, K
    ONKOLOGIE, 1987, 10 (05): : 279 - 280
  • [5] LOW-DOSE ARA-C(LODAC) IN ACUTE MYELOID-LEUKEMIA
    AMADORI, S
    PETTI, MC
    AVVISATI, G
    SIKOGLOU, N
    MANDELLI, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 185 - 185
  • [6] CLOFARABINE IN COMBINATION WITH CYTARABINE (ARA-C) FOR TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN ADULT PATIENTS
    Malato, A.
    Santoro, A.
    Magrin, S.
    Felice, R.
    Turri, D.
    Di Bella, R.
    Salemi, D.
    Acquaviva, F.
    Scime, R.
    Fabbiano, F.
    HAEMATOLOGICA, 2012, 97 : 502 - 503
  • [7] Mitoxantrone, etoposide, carboplatinum and ara-C combination therapy (Meca) in refractory and relapsed acute leukemia
    Ferrá, C
    Berlanga, JJ
    Gallardo, D
    Ancín, I
    Marín, D
    González, JR
    Peris, J
    Muñoz, J
    Sarrá, J
    Grañena, A
    LEUKEMIA & LYMPHOMA, 2000, 39 (5-6) : 583 - 590
  • [8] IDARUBICIN PLUS INTERMEDIATE-DOSE ARA-C IN REFRACTORY AND RELAPSING ADULT ACUTE MYELOID-LEUKEMIA
    DELASERNA, FJ
    TOMAS, JF
    SOLANO, C
    DIAZMEDIAVILLA, J
    SANCHEZ, JJ
    GARCIADEPAREDES, ML
    BLOOD, 1994, 84 (10) : A304 - A304
  • [9] Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia
    Richard L Momparler
    Experimental Hematology & Oncology, 2 (1)
  • [10] INTERMEDIATE DOSE ARA-C AND AMSA FOR TREATMENT OF RELAPSED AND REFRACTORY ADULT AML
    JEHN, U
    KOLB, HJ
    WILMANNS, W
    BLUT, 1988, 57 (04): : 190 - 190
12345